[ad_1]
15:30
Sunday 22 November 2020
Agencies
The US Food and Drug Administration has granted emergency approval to use a treatment for Covid-19, which was developed by the biotech company “Regeneron”.
The approved drug was used to treat US President Donald Trump when he contracted Covid-19.
“France Press” quoted US Food and Drug Administration official Stephen Hahn as saying that “allowing these monoclonal antibody treatments can allow patients to avoid hospitalization and reduce the burden on our healthcare system.”
For his part, Regeneron CEO Leonard Schleifer said this constitutes “an important step in the fight against Covid-19, as high-risk patients in the United States will be able to obtain promising treatment in the early stages of course of infection “.
The green light was given to Regeneron’s treatment, called Regen-Cove-2, which is a combination of two antibodies, after it was shown to reduce Covid-19 cases requiring hospitalization or emergency room.
On Friday, the American company “Pfizer” and its German partner “Biontech” announced that they have submitted a request to the US Food and Drug Administration to approve the emergency use of the Covid-19 vaccine.
Companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.
And they said they will start shipping the doses immediately, knowing Pfizer expects to have 50 million doses of the vaccine ready this year – enough to protect 25 million people.
.
[ad_2]
Source link
